Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,737,528
  • Shares Outstanding, K 1,396,195
  • Annual Sales, $ 10,735 M
  • Annual Income, $ 4,700 M
  • 60-Month Beta 0.87
  • Price/Sales 4.09
  • Price/Cash Flow 13.07
  • Price/Book 3.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.35
  • Number of Estimates 10
  • High Estimate 0.40
  • Low Estimate 0.07
  • Prior Year 0.35
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.10 +27.01%
on 03/23/20
39.36 -22.23%
on 03/03/20
-6.78 (-18.13%)
since 02/28/20
3-Month
24.10 +27.01%
on 03/23/20
46.13 -33.64%
on 01/09/20
-14.61 (-32.31%)
since 12/27/19
52-Week
24.10 +27.01%
on 03/23/20
46.62 -34.34%
on 12/20/19
-7.77 (-20.24%)
since 03/29/19

Most Recent Stories

More News
Insights on the Worldwide Minimally Invasive Surgical Systems Market (2020 to 2030) - Auris Health, Boston Scientific & Cook Medical Among Others

The "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End User, 25 Countries' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2020-2030"...

BSX : 30.61 (unch)
Proposed Settlement of Canadian BSC Transvaginal Mesh Litigation

Siskinds LLP and Siskinds, Desmeules s.e.n.c.r.l. announced today that a Canada-wide settlement has been reached in a class action related to certain transvaginal mesh devices for treatment of Pelvic Organ...

BSX : 30.61 (unch)
Insights into the U.S. Neurological Devices Market to 2025 - Featuring Axonics, Boston Scientific & Cerenovus Among Others - ResearchAndMarkets.com

The "Neurological Devices Market Analysis, Size, Trends | US | 2019-2025" report has been added to ResearchAndMarkets.com's offering.

BSX : 30.61 (unch)
The Global Electrophysiology Market is expected to grow from USD 3,795.27 Million in 2018 to USD 8,198.47 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.63%

Reportlinker.com announces the release of the report "Global Electrophysiology Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" -...

ABT : 82.40 (+10.52%)
BSX : 30.61 (unch)
MCRPF : 2.2750 (-3.60%)
SIEGY : 40.3100 (-4.82%)
STJ : 80.82 (+0.16%)
Innovative Medical Devices Reshape the Landscape of Patient Monitoring

The medical device industry is undergoing significant changes in terms of efficiency and scope as new technologies push the boundaries of what's possible. Technology is transforming the medical device...

INOTF : 0.0110 (+54.93%)
NMRD : 5.52 (-4.22%)
BSX : 30.61 (unch)
BAX : 79.79 (unch)
SNN : 35.94 (+2.10%)
IRTC : 81.78 (-6.95%)
Bull of the Day: Edwards Lifesciences (EW)

Bull of the Day: Edwards Lifesciences (EW)

MDT : 92.51 (+2.91%)
JNJ : 127.30 (+3.36%)
EW : 198.15 (unch)
BSX : 30.61 (unch)
ABT : 82.40 (+10.52%)
China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market (2020-2024) - Featuring Terumo Corporation, Boston Scientific & Abbott Laboratories Among Others - ResearchAndMarkets.com

The "China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market: Insights, Trends & Forecast (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

ABT : 82.40 (+10.52%)
BSX : 30.61 (unch)
TRUMF : 33.0500 (+22.41%)
The Global Cannula Market is expected to grow from USD 241.12 Million in 2018 to USD 337.52 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.92%

Reportlinker.com announces the release of the report "Global Cannula Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05872112/?utm_source=GNW...

BSX : 30.61 (unch)
MDT : 92.51 (+2.91%)
SNN : 35.94 (+2.10%)
TRUMF : 33.0500 (+22.41%)
The Global Cardiac Mapping Market is expected to grow from USD 1,323.45 Million in 2018 to USD 2,486.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.42%

Reportlinker.com announces the release of the report "Global Cardiac Mapping Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05872120/?utm_source=GNW...

BSX : 30.61 (unch)
MDT : 92.51 (+2.91%)
MCRPF : 2.2750 (-3.60%)
Neuromodulation Devices Market to Hit USD 9.34 Billion by 2026; Increasing Patient Population Worldwide to Feed Market Expansion: Fortune Business Insights(TM)

The global neuromodulation devices market size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period. Steady climb in the prevalence of chronic conditions...

BSX : 30.61 (unch)
LIVN : 43.57 (+2.21%)
MDT : 92.51 (+2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BSX with:

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 32.41
1st Resistance Point 31.51
Last Price 30.61
1st Support Level 29.59
2nd Support Level 28.57

See More

52-Week High 46.62
Fibonacci 61.8% 38.02
Fibonacci 50% 35.36
Fibonacci 38.2% 32.70
Last Price 30.61
52-Week Low 24.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar